Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

19.43
Delayed Data
As of May 02
 +0.32 / +1.67%
Today’s Change
16.60
Today|||52-Week Range
21.49
-5.31%
Year-to-Date
VIVO Regular Dividend: VIVO will begin trading ex-dividend on 05/05/16 with a $0.20 dividend payable to shareholders of record as of 05/09/16.
No recent news for Meridian Bioscience Inc.

Today’s Trading

Previous close19.11
Today’s open19.14
Day’s range18.77 - 19.60
Volume387,964
Average volume (3 months)258,123
Market cap$803.6M
Dividend yield4.12%
Data as of 05/02/2016

Growth & Valuation

Earnings growth (last year)+2.41%
Earnings growth (this year)+2.35%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+3.18%
P/E ratio22.4
Price/Sales3.69
Price/Book4.82

Competitors

 Today’s
change
Today’s
% change
GHDXGenomic Health Inc+0.95+3.61%
AMAGAMAG Pharmaceuticals...-0.84-3.17%
QDELQuidel Corp-0.12-0.69%
ALRPRBAlere Inc0.000.00%
Data as of 05/02/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$0.22
Annual revenue (last year)$194.8M
Annual profit (last year)$35.5M
Net profit margin18.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John A. Kraeutler
EVP-Operations &
Information Systems
Lawrence J. Baldini
Corporate headquarters
Cincinnati, Ohio

Forecasts

Partner Offers

Search for Jobs